Mankind Pharma shares in focus after Q3 net profit drops 16% YoY to Rs 385 crore

Mankind Pharma shares are set to remain in focus on Friday, January 24, after the company reported a 16.5% year-on-year decline in consolidated net profit to Rs 385 crore for the third quarter ended December 31, 2024. In the same period last year, the company posted a net profit of Rs 460…